Cargando…
Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report
BACKGROUND: The clinical management of leprosy Type 1 (T1R) and Type 2 (T2R) reactions pose challenges mainly because they can cause severe nerve injury and disability. No laboratory test or marker is available for the diagnosis or prognosis of leprosy reactions. This study simultaneously screened p...
Autores principales: | Stefani, Mariane M, Guerra, Jackeline G, Sousa, Ana Lucia M, Costa, Mauricio B, Oliveira, Maria Leide W, Martelli, Celina T, Scollard, David M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696458/ https://www.ncbi.nlm.nih.gov/pubmed/19473542 http://dx.doi.org/10.1186/1471-2334-9-75 |
Ejemplares similares
-
In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions
por: Costa, Maurício Barcelos, et al.
Publicado: (2018) -
Multibacillary leprosy patients with high and persistent serum antibodies
to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2
reactions
por: Mizoguti, Danielle de Freitas, et al.
Publicado: (2015) -
Unfinished business - Leprosy still not defeated
por: Scollard, David M.
Publicado: (2019) -
Leprosy treatment: Can we replace opinions with research?
por: Scollard, David M.
Publicado: (2020) -
Treatment and Evaluation Advances in Leprosy Neuropathy
por: Ebenezer, Gigi J., et al.
Publicado: (2021)